‌

US Patent 9808477 Use of nobiletin in cancer treatment

Patent 9808477 was granted and assigned to Macau University of Science and Technology on November, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Macau University of Science and Technology

Current Assignee

Macau University of Science and Technology

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

98084770

Patent Inventor Names

Wen-zhe Ma0

Zhong-wen Yuan0

Ying Xie0

Liang Liu0

Sen-ling Feng0

Xiao-jun Yao0

Date of Patent

November 7, 2017

Patent Application Number

148483580

Date Filed

September 9, 2015

Patent Primary Examiner

‌

Jonathan S Lau

Patent abstract

The present invention discloses a pharmaceutical composition of treating multidrug resistance cancer, comprising a citrus methoxyflavone and a chemotherapeutic drug, in which the citrus methoxyflavone is nobiletin. A method of treating multidrug resistance cancer comprising administrating citrus methoxyflavone and a chemotherapeutic drug is also disclosed.